Patriot Financial Group Insurance Agency, LLC Novavax Inc Transaction History

Patriot Financial Group Insurance Agency, LLC

$720 Million
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	SELL	$36.28 - $75.29 $253 - $527	-7 Reduced 12.96%	47 $2,000
Q1 2022 May 11, 2022	BUY	$69.73 - $142.9 $976 - $2,000	14 Added 35.0%	54 $4,000
Q4 2021 Jan 10, 2022	SELL	$134.56 - $217.97 $11,168 - $18,091	-83 Reduced 67.48%	40 $6,000
Q3 2021 Nov 24, 2021	BUY	$177.8 - $270.58 $889 - $1,352	5 Added 4.24%	123 $25,000
Q2 2021 Jul 30, 2021	BUY	$121.0 - $257.67 $121 - $257	1 Added 0.85%	118 $25,000
Q1 2021 Apr 29, 2021	BUY	$112.98 - $319.93 $790 - $2,239	7 Added 6.36%	117 $21,000
Q4 2020 Jan 15, 2021	BUY	$78.74 - $139.5 $6,771 - $11,997	86 Added 358.33%	110 $12,000
Q3 2020 Oct 21, 2020	BUY	$79.44 - $178.51 $1,906 - $4,284	24 New	24 $3,000

Others Institutions Holding NVAX

# of Institutions

290

Shares Held

93.4M

Call Options Held

6.95M

Put Options Held

9.4M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.

Account